Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Medical Informatics

Date Submitted: Nov 24, 2025
Open Peer Review Period: Dec 3, 2025 - Jan 28, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Challenges and Facilitation Approaches for the Participatory Design of AI-based clinical decision support systems – A scoping review

  • Tabea Rambach; 
  • Patricia Gleim; 
  • Carolin Heizmann; 
  • Philipp Kellmeyer; 
  • Christophe Kunze

ABSTRACT

Background:

Artificial intelligence (AI)- based clinical decision support systems (CDSS) can improve diagnostics and treatment decisions, but they are rarely implemented in practice. Barriers include limited integration into clinical workflows, lack of transparency, and insufficient involvement of end users in system design. Participatory and user-centered approaches offer ways to address these challenges by aligning development processes with the needs and routines of clinical staff. However, systematic evidence on how such approaches are applied in the development of AI-based CDSS remains limited.

Objective:

The objective of our study was to examine how participatory approaches are used in the development, piloting, and implementation of AI-based CDSS. We analyzed which user perspectives were included, which participatory methods were applied, how they contributed to technical design, and which ethical, legal, and social implications were addressed.

Methods:

This scoping review followed the PRISMA ScR guideline, with a protocol published in advance. A systematic search was conducted in MEDLINE, ACM Digital Library, CINAHL, and PsycInfo for studies published from 2012 onward, complemented by snowballing and manual searches. Primary studies in English or German were included if they involved clinical staff in the development, piloting, implementation, or evaluation of AI-based CDSS. Two independent reviewers conducted screening and data extraction, resolving disagreements by consensus. Data analysis followed JBI methodology and focused on the scope of participation, theoretical and methodological foundations, and reported impacts of participatory approaches.

Results:

Of 3,177 identified records, 17 met the inclusion criteria. The studies showed broad variation in terminology and methods, most often describing user-centered or iterative processes and less frequently co-design. Physicians were involved in nearly all studies, nurses frequently, and other professional groups only occasionally. Participation mainly supported requirements analysis, adaptation of models to clinical workflows, and the design of explainable interfaces. In several projects, it also influenced data selection, annotation, and visualization. Common barriers included time constraints, limited continuity of participation, and uncertainty toward AI. Ethical, legal, and social aspects mainly were addressed implicitly through themes such as autonomy, responsibility, and traceability, while fairness and bias were rarely discussed.

Conclusions:

Participatory processes in AI-based CDSS development should extend across all stages of system design and address not only usability but also data quality, bias, and broader ethical, legal, and social issues. Equal inclusion of nursing and therapeutic expertise is essential to reflect the diversity of clinical decision-making. Clear methodological standards are needed to ensure comparability and to strengthen participation as a genuine co-design process shaping data, models, and values in clinical AI.


 Citation

Please cite as:

Rambach T, Gleim P, Heizmann C, Kellmeyer P, Kunze C

Challenges and Facilitation Approaches for the Participatory Design of AI-based clinical decision support systems – A scoping review

JMIR Preprints. 24/11/2025:88368

DOI: 10.2196/preprints.88368

URL: https://preprints.jmir.org/preprint/88368

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.